Holding Steady With Treatment When It's Working
- “Bachelorette” alum Katie Thurston, 34, shared that her liver tumor is now undetectable on scans, signaling major progress in her metastatic breast cancer treatment.
- Her treatment journey shifted after she received a second opinion. Thurston’s diagnosis changed from stage 3 triple-positive to stage 4 HER2-negative breast cancer—prompting a critical shift in her treatment plan. She is currently undergoing precision-based targeted therapy, which focuses on proteins that influence cancer cell growth and spread.
- According to Cancer Cell International, “Triple-positive breast cancer (TPBC), a unique subtype of luminal breast cancer, is characterized by concurrent positivity for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).”
- This subtype accounts for only 5–10% of all breast cancer cases and typically requires a multi-pronged treatment approach, including chemotherapy, HER2-targeted therapy, and hormone (endocrine) therapy.
- HER2, short for Human Epidermal Growth Factor Receptor 2, is a protein that can accelerate the growth of breast cancer cells. Its presence—or absence—plays a critical role in determining treatment options. Traditionally, the presence of HER2 has been divided into two groups, either positive or negative, leaving about 50% of patients somewhere in the middle, medical oncologist Elizabeth Comen explains to SurvivorNet.
- Thurston’s treatment initially called for a double mastectomy (removal of both breasts). However, she chose to delay the procedure after consulting with her doctors, citing the need to stay on her current targeted therapy medication without interruption since it was working to shrink tumors.
“You can’t even see it on a scan,” Thurston revealed on the SHE MD Podcast, offering fans a hopeful update on her treatment progress.

WATCH: Second Opinions on Your Cancer Diagnosis or Treatment: Do You Need One?
But after seeking a second opinion, Thurston learned her diagnosis had changed: she was now facing stage 4 HER2-negative breast cancer. That revelation dramatically altered her treatment plan.
“I was very close to being treated potentially with the wrong medication,” she said.
HER2, short for Human Epidermal Growth Factor Receptor 2, is a protein that can accelerate the growth of breast cancer cells. Its presence—or absence—plays a critical role in determining treatment options.
As Dr. Elizabeth Comen, a medical oncologist, explained to SurvivorNet, “These receptors, I like to imagine them like little hands on the outside of the cell… they can grab hold of what we call ligands… hormones that may be circulating in the bloodstream… and used as a fertilizer, as growth support for the cells.”
Traditionally, HER2 status has been classified as either positive or negative, though about half of patients fall into a gray area between the two. HER2-positive cancers, which make up roughly 15–20% of breast tumors, tend to grow and spread more rapidly—but they’re also more likely to respond to targeted drugs like Enhertu.
Thurston’s updated diagnosis meant pivoting to a more precise treatment strategy. While specific details of her regimen haven’t been disclosed, she confirmed she’s undergoing targeted therapy—a form of precision medicine that, according to the National Cancer Institute, “targets proteins that control how cancer cells grow, divide, and spread.”
Her story is a powerful reminder of the importance of second opinions, accurate diagnosis, and personalized treatment.
Expert Resources for Metastatic Breast Cancer
- Do You Have HER2-Positive Metastatic Breast Cancer? Here’s A Breakdown Of Some Of Your Treatment Options
- Chemo Plus Immunotherapy for Metastatic Triple-Negative Breast Cancer
- Metastatic Breast Cancer Sees Advancements in ‘New Era’ of HER2 Classification; Understanding HER2 Breast Cancer
- Metastatic Breast Cancer: Biomarkers and Mutations That Matter
- HER2-Positive Metastatic Breast Cancer Treatment Options Explained
- How Does Piqray Work For HER2-Negative, HR+ Metastatic Breast Cancer?
Targeted Therapy Brings Potential Side Effects
Although targeted therapy can be quite helpful, it comes with side effects. If you experience any abnormal symptoms, contacting your doctor should become a top priority. Patients who are taking more than one immunotherapy drug, referred to as combination therapy, are at an increased risk of experiencing side effects.
WATCH: Understanding HER2-Negative And Ultra-Low: What It Means For Your Breast Cancer Treatment Options
Common immunotherapy side effects include:
- Nausea/vomiting
- Decreased white blood cell count
- Anemia: decreased hemoglobin
- Fatigue
- Constipation
- Decreased appetite
There were several other potential side effects listed as well. Before beginning any new treatment, it’s important to discuss potential side effects with your doctor or medical team. To help manage the side effects, the healthcare provider may:
- Reduce the dose
- Delay the dose
- Or even stop the medication.

Katie’s Ongoing Treatment
Thurston previously shared that her treatment regimen includes three key medications:
- Kisqali (ribociclib): Approved by the FDA in 2017, this targeted therapy is used in combination with endocrine therapy to treat HR+/HER2- breast cancer. It works by slowing the progression of cancer, offering a more tolerable alternative to traditional chemotherapy.
- Lupron (leuprolide): A hormone therapy injection that lowers estrogen levels in the body, helping to prevent the cancer from growing.
- Letrozole: An aromatase inhibitor that reduces the body’s estrogen production, commonly used in postmenopausal women with hormone-sensitive breast cancer.
Treatment Options for Advanced Breast Cancer
Metastatic breast cancer (also called stage 4) means cancer cells have spread from the breast to other parts of the body, which may include the bones, liver, lungs, brain, and beyond.
Breast cancer spreads through the bloodstream or lymphatic system. The blood carries cancer cells to different body parts, where they grow as new tumors.
As the cancer spreads to other body parts, patients may experience additional symptoms depending on where the cancer has spread. Examples include:
- Bones: Severe bone pain or fractures
- Lungs: Difficulty breathing, chest pain, new cough
- Liver: Yellowing of the skin (jaundice), abdominal pain, nausea, and/or vomiting
- Brain: Headaches, memory loss, changes in vision, seizures
WATCH: Treatment options for metastatic breast cancer.
Although stage 4 breast cancer is not curable, several treatment options exist that can extend the life of patients. Treatment options depend on the stage, type of primary breast cancer, and whether hormone receptors are positive.
Treatment can include a combination of:
- Chemotherapy: Oral or IV medications that are toxic to tumor cells
- Hormonal therapies: Drugs that lower estrogen levels or block estrogen receptors from allowing the cancer cells to grow
- Targeted therapies: Drugs that target your tumor’s specific gene mutations
- Immunotherapy: Medications that stimulate your immune system to recognize and attack cancer cells
- Radiation: The use of high-energy rays to kill tumor cells and shrink tumors
- Surgery: To remove a cancerous tumor or lymph nodes (uncommon with stage IV; more common in stages I, II, and III)
- Clinical trials: Studies of new medications, treatments, and other therapies offer hope for better outcomes.
Questions to Ask Your Doctor
If you’re facing the option of having a mastectomy, here are some questions to consider asking your doctor:
- What can I do to prepare for a double mastectomy?
- What happens before and after the procedure?
- For reconstruction, what are the benefits of using implants over my own tissue and vice versa?
- What should I know about implants?
- What will recovery look like after the procedure?
Learn more about SurvivorNet's rigorous medical review process.
